98%
921
2 minutes
20
Background: Dermal fillers have become prevalent in aesthetic surgery, offering noninvasive solutions for addressing signs of aging and enhancing facial features.
Methods: In this study, the in vivo administration of dermal fillers, including a hyaluronic-cross-linked filler (HA-R), a PDLLA-HA combined filler (HA-PDLLA), a microparticle PDO filler (PDO), a PN filler extracted from salmon milt (PN), and pure hyaluronic acid (HA), along with PBS as a control, was evaluated over a 12 week period.
Results: HA-R exhibited sustained volume retention, contrasting with rapid volume loss observed with PN, and gradual dissolution of PDO by week 12. Histological evaluation revealed varying inflammatory responses, with PDO showing notable alleviation of inflammation after 8 weeks. MT staining demonstrated increased collagen formation post-injection, peaking at 4 weeks for most fillers. Immunofluorescent staining highlighted the initial promotion of collagen synthesis by PDO and HA-PDLLA, followed by a subsequent decline after 8 weeks.
Conclusion: This study provided comprehensive insights into the biophysical properties and efficacy of various dermal fillers in stimulating collagen production. PDO and HA-PDLLA initially demonstrated efficacy in promoting collagen synthesis, but limitations were noted in sustaining long-term collagen production. Understanding the dynamics of filler administration and its impact on tissue response is essential for optimizing outcomes in aesthetic surgery practice.
No Level Assigned: This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00266-025-05195-y | DOI Listing |
J Drugs Dermatol
September 2025
Background: Soft-tissue filler injection-related vascular complications (IRVC) can lead to tissue necrosis, vision loss, and stroke. Hyaluronidase-based injections are the mainstay of treatment, though other options include heat, massage, nitroglycerin, and anticoagulants. Given the narrow therapeutic window and limited early warning signs, we propose training residents to implement a standardized soft-tissue filler vascular complication (SFVC) management protocol.
View Article and Find Full Text PDFJ Drugs Dermatol
September 2025
Background: Hyaluronic acid (HA) is a key component naturally present in the skin and is commonly used in skincare formulations and dermal fillers. Recently, there has been growing interest in oral HA supplementation for maintaining skin health and preventing aging due to its potential systemic benefits.
Objective: This study aims to provide a comprehensive analysis of the efficacy of oral HA supplementation on various skin parameters, including hydration, elasticity, firmness, wrinkle reduction, and transepidermal water loss.
While noninflammatory nodules after hyaluronic acid (HA) filler injection are a relatively common phenomenon, delayed-onset nodules (DONs) are relatively uncommon and a significant complication of HA filler treatment. DONs can be inflammatory, granulomatous, or infectious. Infectious nodules are a significant concern for aesthetic providers due to the development of biofilms, and understanding the pathophysiology, diagnosis, and management of DONs is essential for clinicians to minimize risks and optimize patient outcomes.
View Article and Find Full Text PDFJ Cosmet Dermatol
September 2025
Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Background: Patients treated with cancer therapies often experience changes in physical appearance, body image perception, and self-esteem, which influence their quality of life (QoL).
Aims: To assess the effect of treatment with hyaluronic acid (HA) dermal fillers on QoL, safety, and perceived skin changes of oncology patients.
Methods: A single-center prospective study conducted between 2021 and 2023 among female oncology patients aged 30-70 years receiving active cancer treatment.
J Craniofac Surg
September 2025
You and I Clinic, Seoul, Republic of Korea.
Nasolabial folds significantly impact facial appearance and are a common aesthetic concern. This article reviews anatomic considerations and filler injection techniques for treating these folds, with a focus on the Korean population. The dermal filler used in this study is Maili hyaluronic acid filler (Sinclair Pharma), derived from a novel proprietary manufacturing technology known as OxiFree™ technology (Kylane Laboratoires , Switzerland).
View Article and Find Full Text PDF